Venture
Inscripta, Inc.
Latest Form D 2023-06-01- CIK 1667561
- State CA
- Biotechnology
- 14 Form D offerings since 2016-05-11
- Total sold
- $474M
- across 14 offerings
- Rounds
- 14
- Form D offerings since 2016-05-11
- Latest round
- $1.9M
- 2023-06-01 · 021-483102
- Investors
- 2
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2023-06-01 · $1.9M
- 2016-05-11$3M021-262962
- 2016-05-11$6M021-262966
- 2017-03-01$23M021-281559
- 2018-03-07$1M021-307149
- 2018-03-07$55.5M021-307152
- 2018-09-17$1.1M021-321524
- 2019-01-22$50M021-331081
- 2019-12-11$92.1M021-355311
- 2020-11-30$8.1M021-381671
- 2020-11-30$50M021-381672
- 2021-04-14$150M021-395770
- 2023-01-18$4.4M021-471087
- 2023-01-18$27.8M021-471093
- 2023-06-01$1.9M021-483102
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($150M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-483102 | First filed2023-06-01 | Latest2023-06-01 | Sought$1.9M | Sold$1.9M | Investors2 | Exemptions506(b) |
| 021-471093 | First filed2023-01-18 | Latest2023-01-18 | Sought$27.8M | Sold$27.8M | Investors5 | Exemptions506(b) |
| 021-471087 | First filed2023-01-18 | Latest2023-01-18 | Sought$4.4M | Sold$4.4M | Investors4 | Exemptions506(b) |
| 021-395770 | First filed2021-04-14 | Latest2021-04-14 | Sought$150M | Sold$150M | Investors32 | Exemptions506(b) |
| 021-381672 | First filed2020-11-30 | Latest2020-11-30 | Sought$50M | Sold$50M | Investors6 | Exemptions506(b) |
| 021-381671 | First filed2020-11-30 | Latest2020-11-30 | Sought$8.1M | Sold$8.1M | Investors1 | Exemptions506(b) |
| 021-355311 | First filed2019-12-11 | Latest2019-12-11 | Sought$125M | Sold$92.1M | Investors12 | Exemptions506(b) |
| 021-331081 | First filed2019-01-22 | Latest2019-04-15 | Sought$50M | Sold$50M | Investors14 | Exemptions506(b) |
| 021-321524 | First filed2018-09-17 | Latest2018-09-17 | Sought$1.1M | Sold$1.1M | Investors9 | Exemptions506(b) |
| 021-307152 | First filed2018-03-07 | Latest2018-03-07 | Sought$55.5M | Sold$55.5M | Investors14 | Exemptions506(b) |
| 021-307149 | First filed2018-03-07 | Latest2018-03-07 | Sought$1M | Sold$1M | Investors1 | Exemptions506(b) |
| 021-281559 | First filed2017-03-01 | Latest2017-03-01 | Sought$23M | Sold$23M | Investors10 | Exemptions506(b) |
| 021-262966 | First filed2016-05-11 | Latest2016-05-11 | Sought$6M | Sold$6M | Investors2 | Exemptions506(b) |
| 021-262962 | First filed2016-05-11 | Latest2016-05-11 | Sought$3M | Sold$3M | Investors2 | Exemptions506(b) |
Who backs Inscripta, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-06-01
| Name | Relationship |
|---|---|
| Sri Kosaraju | RelationshipExecutive Officer, Director |
| Justin Ferber | RelationshipExecutive Officer |
| Kristala L. Jones Prather | RelationshipDirector |
| Bryan Roberts | RelationshipDirector |
| John R. Stuelpnagel | RelationshipDirector |
| Roger Wyse | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2016-05-11
- Latest filing
- 2023-06-01
Who backs Inscripta, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗